42 related articles for article (PubMed ID: 21695793)
21. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
Griffioen M; van Egmond HM; Barnby-Porritt H; van der Hoorn MA; Hagedoorn RS; Kester MG; Schwabe N; Willemze R; Falkenburg JH; Heemskerk MH
Haematologica; 2008 Oct; 93(10):1535-43. PubMed ID: 18768532
[TBL] [Abstract][Full Text] [Related]
22. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
23. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
[TBL] [Abstract][Full Text] [Related]
24. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
26. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
Yang S; Darrow TL; Seigler HF
Cancer Res; 1997 Apr; 57(8):1561-8. PubMed ID: 9108460
[TBL] [Abstract][Full Text] [Related]
27. The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.
Kajikawa M; Li PC; Goto E; Miyashita N; Aoki-Kawasumi M; Mito-Yoshida M; Ikegaya M; Sugita Y; Ishido S
J Virol; 2012 May; 86(9):5288-96. PubMed ID: 22379101
[TBL] [Abstract][Full Text] [Related]
28. Functional testing of a bicistronic retroviral vector for intracellular peptide production.
Duch M; Tolstrup A; Dalum I; Jespersen T; Mouritsen S; Pedersen FS
Biotechniques; 1999 Jun; 26(6):1032-4, 1036. PubMed ID: 10376133
[No Abstract] [Full Text] [Related]
29. Functional organization of MIR2, a novel viral regulator of selective endocytosis.
Sanchez DJ; Coscoy L; Ganem D
J Biol Chem; 2002 Feb; 277(8):6124-30. PubMed ID: 11751860
[TBL] [Abstract][Full Text] [Related]
30. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.
Heemskerk MH; Hooijberg E; Ruizendaal JJ; van der Weide MM; Kueter E; Bakker AQ; Schumacher TN; Spits H
Cell Immunol; 1999 Jul; 195(1):10-7. PubMed ID: 10433792
[TBL] [Abstract][Full Text] [Related]
31. Retroviral expression of MIR2 decreases both surface MHC class I and the alloimmune CTL response.
Thakur A; Hummel J; Sengupta R; Gupta V; Mossman K; Jones K
J Tissue Eng Regen Med; 2011 Jul; 5(7):520-8. PubMed ID: 21695793
[TBL] [Abstract][Full Text] [Related]
32. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
33. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
34. Control of human herpes virus type 8-associated diseases by NK cells.
Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
[TBL] [Abstract][Full Text] [Related]
35. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Schendel DJ; Frankenberger B; Jantzer P; Cayeux S; Nöbetaner E; Willimsky G; Maget B; Pohla H; Blankenstein T
Gene Ther; 2000 Dec; 7(23):2007-14. PubMed ID: 11175312
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
